Neogenomics Inc (NEO)

R&D Expense Growth

12.87%

Quarterly · Period ending:

NEO logo

NEO R&D Expense Growth

Latest reported12.87%
NEO Quarterly R&D Growth (QoQ) (0.00% → 12.87%)
High-resolution chart · PNG

NEO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.